Upon combining with PD‐L1 blockade, HMME/R837@Lip‐augmented SDT resulted in 95% eradiation of the primary 4T1 tumor as well as 83% eradiation of the distant tumor, which was a significantly better result than anti—PD‐L1 alone. This evidence concerns the gene CD274 and neoplasm.